On the shoulder of ADC: The development of 124I-IMMU-132, an iodine-124-labelled Trop-2-targeting molecular probe for micro-PET imaging

Autor: Zeng, Ziqing, Zheng, Yong, Yan, Xieqiao, Tao, Jinping, Li, Liqiang, Ding, Jin, Sheng, Xi’nan, Zhu, Hua, Yang, Zhi

Publikováno v: In Biomedicine & Pharmacotherapy September 2024 178

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[¹⁷⁷Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.

Autor: Zeng, Ziqing, Li, Liqiang, Tao, Jinping, Liu, Jiayue, Li, Hongjun, Qian, Xueming, Yang, Zhi, Zhu, Hua

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging; Apr2024, Vol. 51 Issue 5, p1221-1232, 12p

Sunspot drawings handwritten character recognition method based on deep learning

Autor: Zheng, Sheng, Zeng, Xiangyun, Lin, Ganghua, Zhao, Cui, Feng, Yongli, Tao, Jinping, Zhu, Daoyuan, Xiong, Li

Publikováno v: In New Astronomy May 2016 45:54-59

[ ¹⁷⁷ Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.

Autor: Zeng Z; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li L; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China., Tao J; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China., Liu J; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li H; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China., Qian X; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China., Yang Z; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China. pekyz@163.com., Zhu H; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, 100142, China. zhuhuabch@pku.edu.cn.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Apr; Vol. 51 (5), pp. 1221-1232. Date of Electronic Publication: 2023 Dec 08.